Waters Corporation WAT

433.54 3.24 0.75% as of 25 Sep
Market cap
$42.3B
P/E
108×
Indexes indicate stock being part of an index,
Insider Buys alert about insiders buying in the last 12 month

Waters Corporation (WAT) P/S ratio

As of 25 September 2026, Waters Corporation (WAT) trades at a P/S ratio of 9.2×. Over the past ten years it has ranged from 4.6× (March 2020) to 9.8× (September 2021); the current reading is higher than 99% of that period. That is above the Diagnostics & Research industry median of 4.9× and above the Healthcare sector median of 3.8×.

P/S ratio, daily

Annual

Period P/S ratio Change
FY2025 7.1× (4.02%)
FY2024 7.4× 13.31%
FY2023 6.6× (5.86%)
FY2022 7.0× (15.30%)
FY2021 8.2× 26.79%
FY2020 6.5× (1.08%)
FY2019 6.6× 9.39%
FY2018 6.0× (11.24%)
FY2017 6.8× 32.98%
FY2016 5.1× (6.28%)

Quarterly

Period P/S ratio Change
Jun 2026 7.9× 22.23%
Mar 2026 6.5× (9.15%)
Dec 2025 7.1× 24.26%
Sep 2025 5.7× (15.74%)
42 more quarters

Against its own ten years

Low 4.6× High 9.8×
Ten-year median 6.4×
Current reading's percentile 99

P/S ratio against peers

Company P/S ratio
DGX Quest Diagnostics Incorporated compare 2.3×
IQV IQVIA Holdings Inc. compare 2.6×
A Agilent Technologies, Inc. compare 6.6×
MTD Mettler-Toledo International, Inc. compare 7.4×
IDXX IDEXX Laboratories, Inc. compare 9.0×
ILMN Illumina, Inc. compare 9.2×
WAT Waters Corporation 9.2×
GH Guardant Health, Inc. compare 19.9×
NTRA Natera, Inc. compare 21.8×
Diagnostics & Research industry median 4.9×
Healthcare sector median 3.8×
Market median 2.0×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on WAT